Kim Forest Enterprise Co., Ltd.

Research Kim Forest Enterprise Co., Ltd. (6645.TW) on Bullrun: market cap TWD 866.51M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 866.51M.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 866.51Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Kim Forest Enterprise Co., Ltd.

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

BIONET Corp. (1784.TWO) DIVA Laboratories, Ltd. (4153.TWO) Genetics Generation Advancement Corp. (4160.TWO) Sofiva Genomics Co.,Ltd. (6615.TWO) Welgene Biotech Co.,Ltd. (6661.TWO) Synbio Tech Inc. (1295.TWO) St.Shine Optical Co.,Ltd. (1565.TWO) Grape King Bio Ltd (1707.TW) Standard Chemical & Pharmaceutical Co., Ltd. (1720.TW) Maywufa Company Ltd. (1731.TW) Apex Biotechnology Corp. (1733.TW) Sinphar Pharmaceutical Co.,Ltd. (1734.TW)

Frequently asked questions

What is Kim Forest Enterprise Co., Ltd.'s market cap?

Kim Forest Enterprise Co., Ltd.'s market capitalization is TWD 866.51M.

What does Kim Forest Enterprise Co., Ltd. do?

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of various genetic and medical testing services.